The complex role of nitric oxide in the regulation of glomerular ultrafiltration

被引:35
作者
Blantz, RC
Deng, AH
Lortie, M
Munger, K
Vallon, V
Gabbai, FB
Thomson, SC
机构
[1] Univ Calif San Diego, Dept Med, Div Nephrol Hypertens, San Diego, CA 92103 USA
[2] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA
关键词
nitric oxide synthase; tubuloglomerular feedback; NMDA; receptor; hemodynamics;
D O I
10.1046/j.1523-1755.2002.00220.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Nitric oxide is an important neurohumoral modulator of glomerular ultrafiltration and renal hemodynamics. Multiple nitric oxide synthase (NOS) isoforms are present within the kidney. However, it is difficult to discern which NOS is most active from prior studies using non-selective NOS blockers. It is recently apparent that NOS activity is important to the activity of tubuloglomerular feedback (TGF) systems, systems that relate tubular reabsorption to the regulation of glomerular ultrafiltration. Neuronal (nNOS) or brain NOS (bNOS; NOS I) is present within the macula densa, the sensing element of TGF systems. Inhibition of NOS activity and specifically bNOS enhances TGF activity. The TGF system also adapts temporally and these events appear to be dependent upon up-regulation of activity of bNOS within the kidney. Temporal adaptation occurs within one to three hours whereby activation of TGF is followed by a gradual return of the glomerular filtration rate (GFR) and renal blood flow toward normal levels. After 24 hours of benzolamide treatment and withdrawal of this agent, glomerular filtration actually increases to supranormal levels and this is prevented by inhibition of bNOS activity. Factors regulating bNOS activity have not been fully clarified. We have recently observed N-methyl-D-aspartate (NMDA) receptors within the kidney that, when inhibited, result in major reductions in renal blood flow and GFR, suggesting an important role for the NMDA receptor in regulation of renal hemodynamics. Future studies will determine whether NMDA receptor is also an important regulator of bNOS activity and the TGF system.
引用
收藏
页码:782 / 785
页数:4
相关论文
共 19 条
[1]   TAMM-HORSFALL PROTEIN MESSENGER-RNA SYNTHESIS IS LOCALIZED TO THE THICK ASCENDING LIMB OF HENLES LOOP IN RAT-KIDNEY [J].
BACHMANN, S ;
METZGER, R ;
BUNNEMANN, B .
HISTOCHEMISTRY, 1990, 94 (05) :517-523
[2]   Pathophysiology of pre-renal azotemia - Discussion [J].
Blantz, RC ;
Madias, NE ;
Ziegler, T ;
Mehta, RL ;
Steiner, R ;
Ward, DM ;
McDonald, B ;
Gabbai, FB .
KIDNEY INTERNATIONAL, 1998, 53 (02) :512-523
[3]   NITRIC-OXIDE AND ANGIOTENSIN-II - GLOMERULAR AND TUBULAR INTERACTION IN THE RAT [J].
DENICOLA, L ;
BLANTZ, RC ;
GABBAI, FB .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (04) :1248-1256
[4]  
Dingledine R, 1999, PHARMACOL REV, V51, P7
[5]   NMDA RECEPTOR ACTIVATION IN RAT HIPPOCAMPUS INDUCES CYCLIC-GMP FORMATION THROUGH THE L-ARGININE NITRIC-OXIDE PATHWAY [J].
EAST, SJ ;
GARTHWAITE, J .
NEUROSCIENCE LETTERS, 1991, 123 (01) :17-19
[6]   NITRIC-OXIDE MEDIATES VASODILATATION IN RESPONSE TO ACTIVATION OF N-METHYL-D-ASPARTATE RECEPTORS IN BRAIN [J].
FARACI, FM ;
BREESE, KR .
CIRCULATION RESEARCH, 1993, 72 (02) :476-480
[7]   GLOMERULAR AND TUBULAR INTERACTIONS BETWEEN RENAL ADRENERGIC ACTIVITY AND NITRIC-OXIDE [J].
GABBAI, FB ;
THOMSON, SC ;
PETERSON, O ;
WEAD, L ;
MALVEY, K ;
BLANTZ, RC .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1995, 268 (06) :F1004-F1008
[8]   NMDA RECEPTOR ACTIVATION INDUCES NITRIC-OXIDE SYNTHESIS FROM ARGININE IN RAT-BRAIN SLICES [J].
GARTHWAITE, J ;
GARTHWAITE, G ;
PALMER, RMJ ;
MONCADA, S .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1989, 172 (4-5) :413-416
[9]   MODULATION OF ANGIOTENSIN-II-INDUCED VASOCONSTRICTION BY ENDOTHELIUM-DERIVED RELAXING FACTOR IN THE ISOLATED MICROPERFUSED RABBIT AFFERENT ARTERIOLE [J].
ITO, S ;
JOHNSON, CS ;
CARRETERO, OA .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (05) :1656-1663
[10]   EVIDENCE FOR THE ROLE OF NITRIC-OXIDE IN MACULA DENSA CONTROL OF GLOMERULAR HEMODYNAMICS [J].
ITO, S ;
REN, YL .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (02) :1093-1098